175 related articles for article (PubMed ID: 26517700)
1. Impact of Polypharmacy on Adherence to Evidence-Based Medication in Patients who Underwent Percutaneous Coronary Intervention.
Mohammed S; Arabi A; El-Menyar A; Abdulkarim S; AlJundi A; Alqahtani A; Arafa S; Al Suwaidi J
Curr Vasc Pharmacol; 2016; 14(4):388-93. PubMed ID: 26517700
[TBL] [Abstract][Full Text] [Related]
2. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
[TBL] [Abstract][Full Text] [Related]
3. The impact of in-hospital cardiac rehabilitation program on medication adherence and clinical outcomes in patients with acute myocardial infarction in the Lazio region of Italy.
Soldati S; Di Martino M; Rosa AC; Fusco D; Davoli M; Mureddu GF
BMC Cardiovasc Disord; 2021 Sep; 21(1):466. PubMed ID: 34565326
[TBL] [Abstract][Full Text] [Related]
4. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D
BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534
[TBL] [Abstract][Full Text] [Related]
5. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
Kocas C; Abaci O; Oktay V; Coskun U; Bostan C; Yildiz A; Arat Ozkan A; Gurmen T; Ersanli M
J Clin Pharm Ther; 2013 Dec; 38(6):476-9. PubMed ID: 23992279
[TBL] [Abstract][Full Text] [Related]
7. Optimizing prevention and guideline-concordant care in Montenegro.
Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
[TBL] [Abstract][Full Text] [Related]
8. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K
Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896
[TBL] [Abstract][Full Text] [Related]
9. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention.
Hlatky MA; Solomon MD; Shilane D; Leong TK; Brindis R; Go AS
J Am Coll Cardiol; 2013 Jan; 61(3):295-301. PubMed ID: 23246391
[TBL] [Abstract][Full Text] [Related]
10. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
[No Abstract] [Full Text] [Related]
11. Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.
Griffiths B; Lesosky M; Ntsekhe M
S Afr Med J; 2014 Jun; 104(7):483-7. PubMed ID: 25214049
[TBL] [Abstract][Full Text] [Related]
12. Effect of evidence-based cardiac drug therapy on mortality in patients with acute coronary syndrome: Findings from the Gulf COAST registry.
Al-Zakwani I; Zubaid M; Alsheikh-Ali AA; Almahmeed W; Rashed W
Cardiovasc Ther; 2018 Dec; 36(6):e12463. PubMed ID: 30079461
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
[TBL] [Abstract][Full Text] [Related]
14. Predictors of adherence to composite therapy after acute coronary syndromes.
Stabile E; Franzese M; Chianese S; Alfani A; Gerardi D; Colaiori I; Annunziata M; Nappi P; Scalise M; Di Serafino L; Puzone B; Avvedimento M; Leone A; Ilardi F; Piccolo R; Franzone A; Cirillo P; Morisco C; Trimarco B; Esposito G
J Cardiovasc Med (Hagerstown); 2021 Aug; 22(8):645-651. PubMed ID: 33966020
[TBL] [Abstract][Full Text] [Related]
15. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
Welker J; Auer R; Gencer B; Muller O; Cornuz J; Matter CM; Mach F; Windecker S; Rodondi N; Nanchen D
Swiss Med Wkly; 2016; 146():w14275. PubMed ID: 26859223
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Depression and Adherence to Guideline-Directed Medical Therapies Following Percutaneous Coronary Intervention.
Lapa ME; Swabe GM; Rollman BL; Muldoon MF; Thurston RC; Magnani JW
JAMA Netw Open; 2022 Dec; 5(12):e2246317. PubMed ID: 36508214
[TBL] [Abstract][Full Text] [Related]
17. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Anselmino M; Malmberg K; Ohrvik J; Rydén L;
Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
[TBL] [Abstract][Full Text] [Related]
18. Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study.
Ivers NM; Schwalm JD; Jackevicius CA; Guo H; Tu JV; Natarajan M
Can J Cardiol; 2013 Nov; 29(11):1408-14. PubMed ID: 23816280
[TBL] [Abstract][Full Text] [Related]
19. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
[TBL] [Abstract][Full Text] [Related]
20. Medications adherence post-primary percutaneous coronary intervention in acute myocardial infarction: A population-based cohort study.
Rahhal A; Mahfouz A; Khir F; Okleh N; Aljundi AH; AlKhalaila O; Hamid Y; Al-Amri M; Al-Yafei SA; Al Suwaidi J; Al-Qahtani A; Arafa S; Arabi AR
J Clin Pharm Ther; 2021 Jun; 46(3):772-779. PubMed ID: 33382471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]